Replies to post #495020 on Anavex Life Sciences Corp (AVXL)

[mike_dotcom]

"so why dilute now at a much lower price?" Who says they are diluting now? We have no way of knowing right now if they are actually selling shares. Having them ready to sell may be prudent - especially if they are about to release good news and the stock price goes up substantially.

[williamssc]

"By using a shelf registration statement, we may offer shares of our common stock having an aggregate offering price of up to $150,000,000 from time to time under this prospectus supplement at prices and on terms to be determined by market conditions at the time of offering."

Missling is likely getting prepared for a sharp price increase.

[georgejjl]

Has anyone considered the one question for Anavex Life Sciences for Clock Stop#1 may be:

Do you Anavex Life Sciences have enough cash on hand to fund 3 months of the cost of producing enough blarcamesine for 3 months minimum for people within the EU? There are over 7 million people int the EU who have Alzheimer's and/or dimentia. If Anavex initially captures just 20% of threat 7 million that would be initially approximately 1.4million people taking initially 1 pill per day which means 365.25 days in a year or initially or 511.35 million blarcamesine pills per year at a minimum.

Blarcamesine needs 511.35 million blarcamesine pills per year at a minimum for just a 20% market capture of people with Alzheimer's and MCI in the EU.

Good luck and GOD bless,

[crescentmotor]

The last offering was at $21 for $50M—so why dilute now at a much lower price?

Because AVXL is, in a few months, facing a binary event that, worse case, could take the stock price down to cash value of less than $1.50/share and the price is what it is ($12.13). AVXL could need money for both a Phase III schizophrenia trial and a second AD Phase III trial. In the absence of other material and positive information, Missling has a responsibility to protect AVXL's going concern status. The timing of any offering is uncertain. At this time, Missling could be getting close to releasing the top line schizophrenia data. If positive, Missling could be aligning the timing of the offering with an increase in the stock price associated with those results. He also could align the timing of the offering with an expected resumption of the AD clock stop in the next month or so. The most conservative move would be to place an offering at the current time. Regardless, Missling was being responsible and prudent when AVXL filed the shelf registration and it should not have caught shareholders off guard.

[pcguy]

Well at a minimum it raises the question if they are raising capital on insider knowledge. The ball is in Anavex court until the end of the clock stop. When is the next review cycle? The best interest of shareholders if confidence is weak is to raise capital to continue additional trials. Theories about needing to raise capital to go to market are weak, if approved there will be no issue raising capital at higher prices. Why raise capital now except to hedge future position?

[Thehubby]

Missling isn't a good leader in my opinion..someone whom i wholly trust and alerted me to this equity feels the same

[LakeshoreLeo1953]

Missling / Transparency?
Military / Intelligence!!!

[WilliamMunny]

Well, you seem to believe, as I do that the clock stop is about to come to an end imminently and that we will know within a couple of weeks or so when the August spreadsheet comes out. Doubt they will sell anything under this ATM until then. Likely will wait to sell much more (unless there is a short squeeze) until the Schizo TLR is out and/or they announce the intended FDA filing within the next 2-3 months, as I expect.

[powerwalker]

So, the registration was for $300 million (July 14th), which the SEC signed off on (July 23rd) and the Prospectus is for $150 million.

To me, that is a good sign that TGD is holding the second tranche in reserve for a latter time. If the worries of you and the other Cassandras were valid, then Dr. Missling would be pulling in the whole $300 million this weekend and not holding anything back.

Please sell if this event bothers you so much. Anavex is being well managed by its executives and time will tell as to its success.


ANAVEX NOW!!!